Annual Drug Patent Expirations for KOSELUGO
Koselugo is a drug marketed by Astrazeneca and is included in one NDA. It is available from one supplier. There are four patents protecting this drug.
This drug has one hundred and forty-two patent family members in thirty-nine countries.
The generic ingredient in KOSELUGO is selumetinib sulfate. One supplier is listed for this compound. Additional details are available on the selumetinib sulfate profile page.
For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com